CD4 and neoplasm: Furthermore, a phase I/II study have shown that CD4+CD25+ Treg depletion improves the graft-vs.-tumor therapeutic effect of donor lymphocyte infusion in patients suffering from hematopoietic malignancies and relapse after standard allogeneic hematopoietic stem cell transplantation (NCT00987987) (165).